Coeptis Pharmaceuticals
Wexford, US · Founded 2018
Biotech
Founders & leadership
DM
David MehalickCEO
DY
Dan YeraceVice-President
Reported raises · per SEC filings
Form D private placements$597KraisedJan 2021 · 9 investors · Pharmaceuticals
Rule 506(b)$917.5KraisedDec 2020 · 16 investors · Pharmaceuticals
Rule 506(b)$18MofferedNov 2018 · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.